Rein Therapeutics, Inc. Financing Cash Flow
Rein Therapeutics, Inc. (RNTX) reported Financing Cash Flow of $52.47 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-14
- Rein Therapeutics, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $47.81M, a 914.75% increase year-over-year.
- Rein Therapeutics, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $4.65M, a 530.62% increase year-over-year.
- Rein Therapeutics, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $2.40M, a 240400.00% increase year-over-year.
- Rein Therapeutics, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $1.90M.
- Rein Therapeutics, Inc. net cash provided by (used in) financing activities for fiscal 2025 was $9.76M, a 45.25% decline from fiscal 2024.
- Rein Therapeutics, Inc. net cash provided by (used in) financing activities for fiscal 2024 was $17.82M, a 12.81% increase from fiscal 2023.
- Rein Therapeutics, Inc. net cash provided by (used in) financing activities for fiscal 2023 was $15.79M.
- Rein Therapeutics, Inc. net cash provided by (used in) financing activities for fiscal 2021 was $55.66M, a 252.26% increase from fiscal 2020.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $47.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $52.47M 10-Q · filed 2026-08-14 | $54.87M derived: sum of 3 quarters · filed 2026-08-14 | $56.77M derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $4.65M 10-Q · filed 2026-05-15 | $7.06M derived: sum of 2 quarters · filed 2026-05-15 | $8.96M derived: sum of 3 quarters · filed 2026-05-15 | $13.67M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $2.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $4.30M derived: sum of 2 quarters · filed 2026-03-26 | $9.02M derived: sum of 3 quarters · filed 2026-08-14 | $9.76M 10-K · filed 2026-03-26 |
| 2025-09-30 | $1.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $6.61M derived: sum of 2 quarters · filed 2026-08-14 | $7.35M 10-Q · filed 2025-11-14 | $7.35M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $4.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $5.45M 10-Q · filed 2026-08-14 | $5.45M derived: sum of 3 quarters · filed 2026-08-14 | $5.00M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $738.00K 10-Q · filed 2026-05-15 | $739.00K derived: sum of 2 quarters · filed 2026-05-15 | $293.00K derived: sum of 3 quarters · filed 2026-05-15 | $18.56M derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | -$445.00K derived: sum of 2 quarters · filed 2026-03-26 | $17.82M derived: sum of 3 quarters · filed 2026-03-26 | $17.82M 10-K · filed 2026-03-26 |
| 2024-09-30 | -$446.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $17.82M derived: sum of 2 quarters · filed 2025-11-14 | $17.82M 10-Q · filed 2025-11-14 | $33.61M derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $18.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $18.26M 10-Q · filed 2025-08-14 | $34.06M derived: sum of 3 quarters · filed 2025-08-14 | $34.06M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-15 | $15.79M derived: sum of 2 quarters · filed 2025-05-15 | $15.79M derived: sum of 3 quarters · filed 2025-05-15 | |
| 2023-12-31 | $15.79M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-07 | $15.79M derived: sum of 2 quarters · filed 2025-04-07 | $15.79M 10-K · filed 2025-04-07 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $0.00 10-Q · filed 2024-11-14 | ||
| 2023-06-30 | $0.00 10-Q · filed 2024-08-14 | |||
| 2021-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | $27.00K derived: sum of 2 quarters · filed 2023-03-20 | $53.00K derived: sum of 3 quarters · filed 2023-03-20 | $55.66M 10-K · filed 2023-03-20 |
| 2021-09-30 | $26.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | $52.00K derived: sum of 2 quarters · filed 2022-11-01 | $55.66M 10-Q · filed 2022-11-01 | $59.90M derived: sum of 4 quarters · filed 2022-11-01 |
| 2021-06-30 | $26.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $55.63M 10-Q · filed 2022-08-15 | $59.87M derived: sum of 3 quarters · filed 2022-08-15 | $60.17M derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $55.60M 10-Q · filed 2022-05-05 | $59.85M derived: sum of 2 quarters · filed 2022-05-05 | $60.14M derived: sum of 3 quarters · filed 2022-05-05 | $71.40M derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | $4.24M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | $4.54M derived: sum of 2 quarters · filed 2022-03-28 | $15.80M derived: sum of 3 quarters · filed 2022-03-28 | $15.80M 10-K · filed 2022-03-28 |
| 2020-09-30 | $298.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $11.56M derived: sum of 2 quarters · filed 2021-11-12 | $11.56M 10-Q · filed 2021-11-12 | $11.54M derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-06-30 | $11.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $11.26M 10-Q · filed 2021-08-11 | $11.24M derived: sum of 3 quarters · filed 2021-08-11 | $11.19M derived: sum of 4 quarters · filed 2021-08-11 |
| 2020-03-31 | $0.00 10-Q · filed 2021-05-11 | -$15.00K derived: sum of 2 quarters · filed 2021-05-11 | -$66.00K derived: sum of 3 quarters · filed 2021-05-11 | $23.80M derived: sum of 4 quarters · filed 2021-05-11 |
| 2019-12-31 | -$15.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-24 | -$66.00K derived: sum of 2 quarters · filed 2021-03-24 | $23.80M derived: sum of 3 quarters · filed 2021-03-24 | $23.96M 10-K · filed 2021-03-24 |
| 2019-09-30 | -$51.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $23.81M derived: sum of 2 quarters · filed 2020-11-12 | $23.98M 10-Q · filed 2020-11-12 | $25.26M derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | $23.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $24.03M 10-Q · filed 2020-08-05 | $25.31M derived: sum of 3 quarters · filed 2020-08-05 | $26.52M derived: sum of 4 quarters · filed 2020-08-05 |
| 2019-03-31 | $165.00K 10-Q · filed 2020-05-11 | $1.44M derived: sum of 2 quarters · filed 2020-05-11 | $2.65M derived: sum of 3 quarters · filed 2020-05-11 | $2.66M derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | $1.28M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $2.49M derived: sum of 2 quarters · filed 2020-03-30 | $2.50M derived: sum of 3 quarters · filed 2020-03-30 | $2.52M 10-K · filed 2020-03-30 |
| 2018-09-30 | $1.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $1.22M derived: sum of 2 quarters · filed 2019-11-07 | $1.24M 10-Q · filed 2019-11-07 | $994.00K derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-06-30 | $12.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $28.00K 10-Q · filed 2019-08-06 | -$216.00K derived: sum of 3 quarters · filed 2019-08-06 | $50.49M derived: sum of 4 quarters · filed 2019-08-06 |
| 2018-03-31 | $16.00K 10-Q · filed 2019-05-08 | -$228.00K derived: sum of 2 quarters · filed 2019-05-08 | $50.47M derived: sum of 3 quarters · filed 2019-05-08 | |
| 2017-12-31 | -$244.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | $50.46M derived: sum of 2 quarters · filed 2019-03-29 | $50.59M 10-K · filed 2019-03-29 | |
| 2017-09-30 | $50.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $50.84M 10-Q · filed 2018-11-07 | ||
| 2017-06-30 | $133.00K 10-Q · filed 2018-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |